Cryosite Ltd (CTE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cryosite Ltd (CTE) has a cash flow conversion efficiency ratio of 0.361x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$1.30 Million ≈ $921.96K USD) by net assets (AU$3.61 Million ≈ $2.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CTE net asset quality index to measure how much of total assets are equity-financed.
Cryosite Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Cryosite Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Cryosite Ltd to evaluate the quality of earnings relative to operating cash generation.
Cryosite Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cryosite Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SG Choongbang Co Ltd
KO:001380
|
-0.005x |
|
Archer Materials Ltd
AU:AXE
|
-0.246x |
|
Canlan Ice Sports Corp.
TO:ICE
|
0.085x |
|
RS GROUP PLC
LSE:RS1
|
0.087x |
|
HCL Infosystems Limited
NSE:HCL-INSYS
|
0.049x |
|
Globalink Investment Inc
NASDAQ:GLLI
|
-0.010x |
|
Korea Electronic Certification Authority Inc
KQ:041460
|
0.036x |
|
Kworld Computer Co Ltd
TWO:3287
|
0.030x |
Annual Cash Flow Conversion Efficiency for Cryosite Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Cryosite Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Cryosite Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$2.39 Million ≈ $1.69 Million |
AU$2.06 Million ≈ $1.46 Million |
0.864x | -54.36% |
| 2024-06-30 | AU$1.45 Million ≈ $1.03 Million |
AU$2.74 Million ≈ $1.94 Million |
1.893x | +274.03% |
| 2023-06-30 | AU$2.78 Million ≈ $1.97 Million |
AU$1.41 Million ≈ $996.25K |
0.506x | -62.25% |
| 2022-06-30 | AU$1.86 Million ≈ $1.32 Million |
AU$2.49 Million ≈ $1.77 Million |
1.341x | +130.27% |
| 2021-06-30 | AU$819.23K ≈ $579.65K |
AU$476.96K ≈ $337.48K |
0.582x | -93.10% |
| 2020-06-30 | AU$154.88K ≈ $109.58K |
AU$1.31 Million ≈ $924.35K |
8.435x | +2135.42% |
| 2019-06-30 | AU$-1.72 Million ≈ $-1.21 Million |
AU$-647.54K ≈ $-458.17K |
0.377x | +379.99% |
| 2018-06-30 | AU$1.94 Million ≈ $1.38 Million |
AU$-261.91K ≈ $-185.32K |
-0.135x | -126.08% |
| 2017-06-30 | AU$3.15 Million ≈ $2.23 Million |
AU$1.63 Million ≈ $1.15 Million |
0.517x | +267.77% |
| 2016-06-30 | AU$3.38 Million ≈ $2.39 Million |
AU$474.61K ≈ $335.82K |
0.140x | -64.86% |
| 2015-06-30 | AU$3.54 Million ≈ $2.51 Million |
AU$1.42 Million ≈ $1.00 Million |
0.400x | +54.74% |
| 2014-06-30 | AU$6.14 Million ≈ $4.34 Million |
AU$1.58 Million ≈ $1.12 Million |
0.258x | -16.57% |
| 2013-06-30 | AU$6.26 Million ≈ $4.43 Million |
AU$1.94 Million ≈ $1.37 Million |
0.310x | -9.74% |
| 2012-06-30 | AU$5.48 Million ≈ $3.88 Million |
AU$1.88 Million ≈ $1.33 Million |
0.343x | +13.39% |
| 2011-06-30 | AU$4.69 Million ≈ $3.32 Million |
AU$1.42 Million ≈ $1.00 Million |
0.303x | +34.76% |
| 2010-06-30 | AU$4.35 Million ≈ $3.08 Million |
AU$977.66K ≈ $691.75K |
0.225x | +37.27% |
| 2009-06-30 | AU$4.34 Million ≈ $3.07 Million |
AU$709.86K ≈ $502.27K |
0.164x | -20.44% |
| 2008-06-30 | AU$4.32 Million ≈ $3.06 Million |
AU$888.27K ≈ $628.51K |
0.206x | +10.08% |
| 2007-06-30 | AU$3.74 Million ≈ $2.64 Million |
AU$697.65K ≈ $493.63K |
0.187x | +358.76% |
| 2006-06-30 | AU$2.81 Million ≈ $1.99 Million |
AU$-203.02K ≈ $-143.65K |
-0.072x | +10.55% |
| 2005-06-30 | AU$2.48 Million ≈ $1.75 Million |
AU$-199.90K ≈ $-141.44K |
-0.081x | +66.81% |
| 2004-06-30 | AU$3.04 Million ≈ $2.15 Million |
AU$-738.72K ≈ $-522.69K |
-0.243x | +20.88% |
| 2002-06-30 | AU$3.89 Million ≈ $2.75 Million |
AU$-1.20 Million ≈ $-845.61K |
-0.307x | -27.31% |
| 2001-06-30 | AU$3.87 Million ≈ $2.74 Million |
AU$-933.52K ≈ $-660.52K |
-0.241x | -- |
About Cryosite Ltd
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial … Read more